List of insiders holdings for Flexion Therapeutics Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Sofinnova Partners SAS 10% Owner | 2016-02-16 13:09:26 | 1,901,491 0 | 1,901,491 | Form 13G |
| Versant Ventures III LLC Versant Venture Capital III L.P. Versant Side Fund III L.P. Versant Development Fund III L.P. ATWOOD BRIAN G COLELLA SAMUEL D JAFFE ROSS A MD LINK WILLIAM J PHD MILDER DONALD B ROBERTSON REBECCA B 10% Owner | 2021-01-25 17:57:58 | 1,388,683 0 | 1,388,683 | Form 13D |
| Novo A/S 10% Owner | 2015-09-30 12:12:07 | 1,033,131 0 | 1,033,131 | Form 13D |
| PFIZER INC 10% Owner | 2016-02-11 17:00:58 | 926,309 0 | 926,309 | Form 13G |
| Bodick Neil Chief Scientific Officer | 2020-01-07 16:28:24 | 100,153 389,683 | 489,836 | Form 4 |
| 5AM Ventures II LP 5AM CO-INVESTORS II LP 10% Owner | 2016-02-11 18:06:06 | 461,563 0 | 461,563 | Form 13G |
| LUBASH BARBARA N Bolzon Bradley J PhD Warden Charles M Praeger Robin L. 10% Owner | 2016-06-10 21:40:32 | 0 409,422 | 409,422 | Form 4 |
| Arkowitz David Chief Financial Officer | 2021-05-12 17:06:20 | 220,719 0 | 220,719 | Form 4 |
| Fratamico Arthur Chief Business Officer | 2014-02-11 20:18:19 | 121,401 0 | 121,401 | Form 3 |
| Mahatme Sandesh Director | 2020-06-12 16:17:55 | 11,500 0 | 11,500 | Form 4 |
| Deniz Yamo Chief Medical Officer | 2017-09-15 17:12:15 | 9,030 0 | 9,030 | Form 4 |
| Tordjman Rafael Director 10% Owner | 2014-03-04 18:45:16 | 9,000 0 | 9,000 | Form 4 |
| Schwab Andrew J. Director 10% Owner | 2014-03-04 18:44:15 | 9,000 0 | 9,000 | Form 4 |
| KELLEY SCOTT Chief Medical Officer | 2021-03-15 18:05:12 | 5,334 0 | 5,334 | Form 3/A |
| Canute Scott A Director | 2021-11-19 10:10:52 | 0 0 | 0 | Form 4 |
| Koppikar Utpal Director | 2021-11-19 10:13:44 | 0 0 | 0 | Form 4 |
| Kwo Elizabeth Director | 2021-11-19 10:14:55 | 0 0 | 0 | Form 4 |
| COLELLA SAMUEL D Director | 2021-11-19 10:12:26 | 0 0 | 0 | Form 4 |
| Andrews William T. Chief Medical Officer | 2021-11-19 09:58:58 | 0 0 | 0 | Form 4 |
| Lukatch Heath Director | 2021-11-19 10:16:24 | 0 0 | 0 | Form 4 |
| MERRIFIELD C ANN Director | 2021-11-19 10:17:43 | 0 0 | 0 | Form 4 |
| MILINAZZO ALAN Director | 2021-11-19 10:19:17 | 0 0 | 0 | Form 4 |
| Stejbach Mark Director | 2021-11-19 10:20:34 | 0 0 | 0 | Form 4 |
| Newtyn Management LLC 10% Owner | 2021-11-23 19:00:12 | 0 0 | 0 | Form 4 |
| MAHAFFY PATRICK J Director | 2021-11-19 10:09:28 | 0 0 | 0 | Form 4 |
| Levine Mark S. General Counsel | 2021-11-19 10:08:00 | 0 0 | 0 | Form 4 |
| Muzikant Adam Chief Business Officer | 2021-11-19 10:06:44 | 0 0 | 0 | Form 4 |
| Wentworth Kerry Chief Regulatory Officer | 2021-11-19 10:04:54 | 0 0 | 0 | Form 4 |
| Layman Melissa Chief Commercial Officer | 2021-11-19 10:03:15 | 0 0 | 0 | Form 4 |
| Willwerth Christina Chief Strategy Officer | 2021-11-19 10:01:34 | 0 0 | 0 | Form 4 |
| DRISCOLL FREDERICK W Chief Financial Officer | 2021-11-19 10:00:04 | 0 0 | 0 | Form 4 |
| Clayman Michael D. President and CEO | 2021-11-19 09:56:54 | 0 0 | 0 | Form 4 |
| Jones Elaine V Director | 2014-02-11 20:19:47 | 0 0 | 0 | Form 3 |